Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | CA1 | P00915 | 4/20 | 0.54 |
| ▸ | CA2 | P00918 | 4/20 | 0.54 |
| ▸ | CA12 | O43570 | 3/20 | 0.54 |
| ▸ | CA7 | P43166 | 3/20 | 0.54 |
| ▸ | CA9 | Q16790 | 3/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.50 |
| ▸ | KDR | P35968 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL163610 | 0.94 | CA1 (0.59) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL596197 | 0.91 | CA1 (0.56) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL460201 | 0.91 | CA1 (0.56) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL5872953 | 0.91 | CA1 (0.56) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL1498023 | 0.91 | CA1 (0.56) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL3427286 | 0.91 | CA1 (0.56) | ALDH1A1CA1CA2CA12CA7 | |
| Lithium SCHEMBL30876345 | 0.91 | CA1 (0.56) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL29178253 | 0.91 | CA1 (0.56) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL22206251 | 0.91 | CA1 (0.56) | ALDH1A1CA1CA2CA12CA7 | |
| SCHEMBL29067035 | 0.91 | CA1 (0.56) | ALDH1A1CA1CA2CA12CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 730 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4168255-B1 | ELASTOMERIC COMPOSITION COMPRISING A PHENOLIC COMPOUND AND A COMPOUND FROM THE MONOSACCHARIDE FAMILY | MICHELIN & CIE (FR) | 2026-03-04 | — | — | EP | claimed |
| EP-4687488-A1 | SWEETNESS AND TASTE IMPROVEMENT OF NON-SUCROSE SWEETENERS WITH HYDROXYBENZOIC ACID | The Coca-Cola Company (US) | 2026-02-11 | — | — | EP | claimed |
| US-20250304851-A1 | METHODS AND COMPOSITIONS USED IN CONTROLLING FORMATION SAND PRODUCTION, PROPPANT FLOWBACK, AND FINES MIGRATION | HALLIBURTON ENERGY SERVICES, INC | 2025-10-02 | — | — | US | claimed |
| CN-119034686-A | Impurity removing material and preparation method and application thereof | 江苏鲁控环境科技有限公司 | 2024-11-29 | — | — | CN | claimed |
| CN-117843276-B | Multi-component composite steel slag grinding-aid excitant and preparation method thereof | 华新水泥股份有限公司 | 2024-11-26 | — | — | CN | claimed |
| WO-2024206222-A1 | SWEETNESS AND TASTE IMPROVEMENT OF NON-SUCROSE SWEETENERS WITH HYDROXYBENZOIC ACID | THE COCA-COLA COMPANY (US) | 2024-10-03 | — | — | WO | claimed |
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | ZEVRA THERAPEUTICS INC. | 2024-09-03 | — | — | US | claimed |
| CN-117843276-A | Multi-component composite steel slag grinding-aid excitant and preparation method thereof | 华新水泥股份有限公司 | 2024-04-09 | — | — | CN | claimed |
| CN-117750886-A | Salt-containing beverage with improved taste | 可口可乐公司 | 2024-03-22 | — | — | CN | claimed |
| EP-4333641-A1 | BEVERAGES COMPRISING SALTS WITH IMPROVED TASTE | The Coca-Cola Company (US) | 2024-03-13 | — | — | EP | claimed |
| EP-1153093-A1 | CHEMICAL COMPOSITION FOR INK | Avecia Limited (GB) | 2001-11-14 | — | — | EP | claimed |
| WO-2000037574-A1 | CHEMICAL COMPOSITION FOR INK | AVECIA LIMITED (GB) | 2000-06-29 | — | — | WO | claimed |
| EP-0443742-B1 | Presensitized plate for use in making lithographic printing plate | FUJI PHOTO FILM CO LTD (JP) | 1997-10-01 | — | — | EP | claimed |
| US-5476754-A | Presensitized; hydrophilic surface on substrate; light sensitive layer containing alkaline water-soluble photocrosslinkable copolycondensed diazo resin | FUJI PHOTO FILM CO., LTD. (JP) | 1995-12-19 | — | — | US | claimed |
| EP-0443742-A2 | Presensitized plate for use in making lithographic printing plate | FUJI PHOTO FILM CO., LTD. (JP) | 1991-08-28 | — | — | EP | claimed |
| US-4813972-A | USING LEVELING DYES, COLORFASTNESS | CIBA-GEIGY CORPORATION (US) | 1989-03-21 | — | — | US | claimed |
| EP-0083971-B1 | PHOTOSENSITIVE COMPOSITION | KONICA CORPORATION (JP) | 1987-04-01 | — | — | EP | claimed |
| US-4536465-A | CONTAINING CARBOXY, OXY, AROMATIC COMPOUND AND ALDEHYDE OR KETONE WITH A NOVOLAK RESIN | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1985-08-20 | — | — | US | claimed |
| EP-0083971-A2 | Photosensitive composition | KONICA CORPORATION (JP) | 1983-07-20 | — | — | EP | claimed |
| US-4150108-A | STEROID ENTRAPPED IN COPOLYMER MATRIX FROM A BIS(DIHYDROPYRAN) | GRAHAM NEIL B | 1979-04-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12076316-B2 | Levorphanol prodrugs and processes for making and using them | OPRM1, OPRL1, OPRK1 | ALDH1A1 1258/4885CA1 1503/4885CA2 3018/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.